Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
Ryoichi Bessho, Yumi Takiyama, Takao Takiyama et al. · Scientific Reports · 2019
Full textCC BYNot checked
2 papers
Ryoichi Bessho, Yumi Takiyama, Takao Takiyama et al. · Scientific Reports · 2019
Full textCC BYNot checked
Debmalya Barh, Rajesh Malhotra, B. Ravi et al. · Current Oncology · 2010
Full textCC BYNot checked